Comparisons of tumor suppressor p53, p21, and p16 gene therapy effects on glioblastoma tumorigenicity in Situ

Biochemical and Biophysical Research Communications

Volumn 287, Issue 1, 2001, Pages 173-180

  Wang, T J ^a   Huang, M S ^b   Hong, C Y ^c   Tse, V ^d   Silverberg, G D ^d   Hsiao, M ^e  

^a CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d STANFORD UNIVERSITY MEDICAL CENTER   (United States)

^e KAOHSIUNG VETERANS GENERAL HOSPITAL   (Taiwan)

Author keywords

Glioblastoma; P16; P21; P53; Tumor suppression

Indexed keywords

PROTEIN P16; PROTEIN P21; PROTEIN P53;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER SURVIVAL; CONTROLLED STUDY; DRUG EFFICACY; GENE DELETION; GENE INSERTION; GENE MUTATION; GENE THERAPY; GLIOBLASTOMA; GROWTH RATE; GROWTH REGULATION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; TUMOR SUPPRESSOR GENE;

EID: 0035860184     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1006/bbrc.2001.5565     Document Type: Article

References (36)

1. Rates of p16 (MTS1) mutations in primary tumors with 9p loss
2. A cell cycle regulator potentially involved in genesis of many tumor types
3. Tumour-derived p16 alleles encoding proteins defective in cell-cycle inhibition
4. Retinoblastoma-protein-dependent cell-cycle inhibition by the tumour suppressor p16
5. Deletions of the cyclin-dependent kinase-4 inhibitor gene in multiple human cancers
6. Restoration of growth arrest by p16INK4, p21WAF1, pRB, and p53 is dependent on the integrity of the endogenous cell-cycle control pathways in human glioblastoma cell lines
7. Cancer cell cycles
8. A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4
9. Inhibition of ras-induced proliferation and cellular transformation by p16INK4
10. Adenovirally transferred p16INK4/CDKN2 and p53 genes cooperate to induce apoptotic tumor cell death
11. p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest
12. WAF1, a potential mediator of p53 tumor suppression
13. Induction of chemosensitivity in human lung cancer cells in vivo by adenovirus-mediated transfer of the wild-type p53 gene
14. Adenovirus-mediated transfer of a wild-type p53 gene and induction of apoptosis in cervical cancer
15. Adenoviral-mediated p53 tumor suppressor gene therapy of human ovarian carcinoma
16. Apoptosis induction mediated by wild-type p53 adenoviral gene transfer in squamous cell carcinoma of the head and neck
17. Adenovirus-mediated p53 gene therapy for human gliomas
18. Adenovirus-mediated p16/CDKN2 gene transfer induces growth arrest and modifies the transformed phenotype of glioma cells
19. P16INK4a expression adenovirus vector to suppress pancreas cancer cell proliferation
20. Adenovirus-mediated transfer of p53 and p16(INK4a) results in pancreatic cancer regression in vitro and in vivo
21. The p21 cyclin-dependent kinase inhibitor suppresses tumorigenicity in vivo
22. Effects of ectopic overexpression of p21(WAF1/CIP1) on aneuploidy and the malignant phenotype of human brain tumor cells
23. The growth inhibitory effect of p21 adenovirus on human bladder cancer cells
24. Inhibition of tumor cell growth by p21WAF1 adenoviral gene transfer in lung cancer
25. Expression of p16(INK4A) induces dominant suppression of glioblastoma growth in situ through necrosis and cell cycle arrest
26. Multidrug resistance in glioblastoma. Chemosensitivity testing and immunohistochemical demonstration of P-glycoprotein
27. Cisplatin resistant glioblastoma cells may have increased concentration of urokinase plasminogen activator and plasminogen activator inhibitor type 1
28. The intrinsic radioresistance of glioblastoma-derived cell lines is associated with a failure of p53 to induce p21(BAX) expression
29. In vivo radiation sensitivity of glioblastoma multiforme
30. Functional expression of human p21(WAF1/CIP1) gene in rat glioma cells suppresses tumor growth in vivo and induces radiosensitivity
31. Mdm2 promotes the rapid degradation of p53
32. Regulation of p53 stability by Mdm2
33. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation
34. Intracavitary liposome-mediated p53 gene transfer into glioblastoma with endogenous wild-type p53 in vivo results in tumor suppression and long-term survival
35. Growth suppression mediated by transfection of p53 in Hut292DM human lung cancer cells expressing endogenous wild-type p53 protein
36. Effects of exogenous wild-type p53 on a human lung carcinoma cell line with endogenous wild-type p53